High Toxicity Risks inside mRNA Vaccines: MODERNA Scientists confirmed Results of Segalla’s Italian Study
Introduction by Fabio Giuseppe Carlo Carisio
We are very pleased to report below an article published by The Epoch Times on yet another study that proves the toxicity of mRNA gene sera in relation to dangerous lipid nanoparticles and their components harmful to the human body.
The new study published in Nature and highlighted by the American newspaper is truly disturbing for many reasons.
First of all, it confirms the results highlighted by the Italian biochemist Gabriele Segalla who is the first to ascertain the toxicity of these nanomaterials in a study on vaccine Comirnaty produced by Pfizer-Biontech and in a subsequent one also the disconcerting circumstance that the European Medicines Agency (EMA), the European drug regulatory body, had to be perfectly aware of the serious inflammatory problems caused by muscle injections of these mRNA gene serums (as also proven by another international research).
Secondly, the new study is disruptive because among the various researchers who signed it there are also two scientists who work for Moderna and who are therefore considered the leading experts on the topic.
Furthermore, it is disconcerting because it places emphasis on the aspect of the severity of the inflammatory risks of lipid nanoparticles (already ascertained by the Thomas Jefferson University Hospital in Boston in a test on mice) which together with the alarm on carcinogenic DNA fragments, for which the Florida’s surgeon general has asked for an immediate stop to Covid vaccine inoculations, represents the definitive condemnation of the new mRNA biotechnology.
Finally the study confirmed, as anticipated by other research published in advance by Gospa News, that mRNA and the spike protein delivered by Moderna’s vaccine in various parts of human beings weeks or months after vaccination, despite health officials claiming when the vaccines were rolled out that such materials would exit the body within days.
The importance of the study cannot be attenuated in the slightest by an enormous conflict of interest of the researcher Eric Jacquinet, Senior Experimental Pathologist with 22 years’ experience including 12 years in major pharmaceutical companies such as Pfizer and Moderna, where he worked until 2 months ago before becoming vice president of the Non-Clinical sector of the new American pharmaceutical company SalioGen which is trying to compete with the others by recruiting the best biotech talents.
The New Frontiers of Genetic Vaccines…
Based in Massachusetts, US, and founded in 2020, SalioGen Therapeutics, Inc. operates as a biotechnology company developing Gene Coding and advancing Exact DNA Integration Technology (EDIT) for non-viral gene therapy. Ray Tabibiazar serves as the CEO, and Chairman of the company as of 2021. In January 2022, SalioGen Therapeutics, Inc. raised USD 115 million in series B funding co-led by new investors EPIQ Capital Group and GordonMD Global Investments, with participation from other new investors.
The main Current Investors are Fidelity Management & Research Company LLC, funds and accounts advised by T. Rowe Price Associates, Inc., D1 Capital Partners, SymBiosis, the Cystic Fibrosis Foundation, the RD Fund (the venture arm of Foundation Fighting Blindness).
On March 1, 2021 SalioGen Therapeutics announced that it has closed a $20 million Series A financing. The round was led by PBM Capital, a healthcare-focused investment firm, and included other undisclosed investors. Proceeds from the financing will be used to support the preclinical validation of the Company’s proprietary Exact DNA Integration Technology (EDIT) platform for the development of durable, safe and affordable in vivo gene therapies,
Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization
follow Fabio Carisio Gospa News director on Twitter
follow Gospa News on Telegram
Moderna Scientists Warn mRNA Vaccines Carry Toxicity Risks
By Zachary Stieber – Originally published by The Epoch Times
All links to Gospa News articles have been added aftermath, in relation to the topics highlighted
Subscribe to the Gospa News Newsletter to read the news as soon as it is published
The technology used in Moderna’s COVID-19 vaccine carries toxicity risks, scientists with the company said in a new paper.
“A major challenge now is how to efficiently de-risk potential toxicities associated with mRNA technology,” the scientists wrote in the paper, which was published by Nature Reviews Drug Discovery on Jan. 23.
The Moderna and Pfizer COVID-19 vaccines use modified messenger ribonucleic acid (mRNA) technology. The mRNA is delivered by lipid nanoparticles (LNP). The toxicity risks include “lipid nanoparticle structural components, production methods, route of administration and proteins produced from complexed mRNAs,” the authors of the paper wrote.
Authors of the paper include Moderna employees Eric Jacquinet and Dimitrios Bitounis and Maximillian Rogers, who was working at Moderna when the paper was being done.
Moderna didn’t respond to a request for comment.
The mRNA vaccines have multiple known side effects, including heart inflammation and severe allergic shock. Those may stem from hypersensitivity reactions, which can be elicited by “any LNP-mRNA component” but are most likely triggered by PEGlyated lipid nanoparticles, which is “the most potentially reactogenic component,” according to the scientists.
Polyethylene glycol, or PEG, an ingredient in the Pfizer and Moderna COVID-19 vaccines, is known to cause allergic reactions. Outside scientists are divided over the mechanism behind the heart inflammation, while Pfizer has posited that the LNPs are behind the issue.
The new paper drew from prior publications and other data. The authors didn’t carry out any new experiments.
Moderna’s vaccine in various parts of human beings weeks or months after vaccination
The scientists said that Moderna’s COVID-19 vaccine is “safe and effective” and hailed the development of an updated vaccine as “[demonstrating] the rapid timeline for modifications with mRNA technology in the clinic.” Due to the “transient nature of mRNA,” however, “repeat administration may be necessary,” they said.
The scientists later noted that reducing risks of toxicities with mRNA-based vaccines and drugs is necessary but “complicated.” That can be accomplished through a multipronged approach that includes advanced testing in laboratories and adjusts preclinical, animal trials to better account for “differences in human and animal physiology.”
Moderna and other companies are currently testing a number of new mRNA products, including influenza vaccines and cancer treatments.
Moderna AWARE that mRNA Jabs cause CANCER due to DNA Fragments. Malone Unveils Patent
“Thanks to the mRNA platform we built, we have an exciting pipeline, with up to 15 launches in the next five years,” Stephane Bancel, Moderna’s CEO, told investors in the company’s most recent earnings call.
The paper’s corresponding author, Mansoor Amiji of Northeastern University’s Departments of Pharmaceutical Sciences and Chemical Engineering, referred a request for comment to Mr. Bitounis, who didn’t provide any answers.
Dr. Malone Reacts
Dr. Robert Malone, who helped invent the mRNA technology, said the paper downplayed the range of risks that have been linked to the mRNA-based vaccines and may be part of a limited hangout, or a propaganda technique.
That technique, a form of misdirection, involves people offering some information to obscure or prevent the discovery of other information.
“A less generous interpretation of intent is that this article represents a subtle form of propaganda strategy commonly referred to as a limited hangout.”
RELATED STORIES – mRNA COVID-19 Vaccines Caused More Deaths Than Saved: Study
By Zachary Stieber – Originally published by The Epoch Times
All links to Gospa News articles have been added aftermath, in relation to the topics highlighted
Subscribe to the Gospa News Newsletter to read the news as soon as it is published
MAIN SOURCES
NATURE – Strategies to reduce the risks of mRNA drug and vaccine toxicity
GOSPA NEWS – COVID-19, VACCINES & BIG PHARMA DOSSIER
GOSPA NEWS – WUHAN-GATES DOSSIER
